In the past several decades, marine organisms have generously gifted to the pharmaceutical
industries numerous naturally bioactive compounds with antiviral, antibacterial, antimalarial …

The role of the marine environment in the development of anticancer drugs has been widely
reviewed, particularly in recent years. However, the innovation in terms of clinical benefits …

There is an immense diversity of marine plants and animals from which an estimated 14,000
pharmacologically active compounds have been isolated. However, in terms of clinically …

By the end of 2017, there were seven marine-derived pharmaceutical substances that have
been approved by the FDA for clinical use as drugs. Four of them are approved for the …

In 2019, the scientific and medical community celebrated the 50th anniversary of the
introduction of the very first marine-derived drug, Cytarabine, into clinics. Cytarabine (aka …

The marine environment represents an outstanding source of antitumoral compounds and,
at the same time, remains highly unexplored. Organisms living in the sea synthesize a wide …

By the end of the year 2020, there are nine marine-derived anticancer drugs available on
the market, and the field is currently growing exponentially. This process is stipulated by …

Marine ecosystems constitute a huge reservoir of biologically active secondary metabolites.
Consequently during the last past few decades, several marine-derived molecules have …

Marine ecosystem represents a wide and untapped reservoir of biologically active
metabolites. Most of the sponges, seaweeds, crustaceans, fish species and their associated …

Various active anticancer agents are derived from plants and terrestrial microorganisms.
Isolation of C-nucleosides from the Caribbean sponge, Cryptotheca crypta, four decades …